Table 3 Medication (n = 780)
Group A Briding (n = 111) | Group B VKA (n = 318) | Group C DOAC (n = 351) | p-value A-B | p-value A-C | p-value B-C | |
|---|---|---|---|---|---|---|
Beta-blockers (n, %) | 106 (95.5) | 277 (87.1) | 304 (86.6) | 1.0 | 0.009 | 0.012 |
ACE-inhibitors (n, %) | 57 (51.4) | 144 (45.3) | 83 (23.6) | < 0.001 | < 0.001 | 0.272 |
AT1 antagonists (n, %) | 26 (23.4) | 69 (21.7) | 90 (25.6) | 0.238 | 0.707 | 0.693 |
Diuretics (n, %) | 28 (25.2) | 112 (35.2) | 104 (29.6) | 0.136 | 0.401 | 0.060 |
Aspirin (n, %) | 13 (11.7) | 21 (6.6) | 9 (2.6) | 0.014 | < 0.001 | 0.102 |
Anti-platelet drugs (n, %) | 3 (2.7) | 11 (3.5) | 1 (0.3) | 0.002 | 0.045 | 1.0 |
Statins (n, %) | 40 (36.0) | 103 (32.4) | 88 (25.1) | 0.04 | 0.029 | 0.485 |